COMP <GO>

BJDX vs ICCM // 10Y YIELD & FRED MACRO BETA

Bluejay Diagnostics Inc. (NASDAQ) VS. IceCure Medical Ltd. (NASDAQ) • 15-METRIC TALLY: BJDX 1 — ICCM 2

■ METRIC PARITY

LAST: $0.53 (-4.74%) • MKT CAP: $2.4M

macro-sensitivity

—

LAST: $0.84 (-3.14%) • MKT CAP: $2.9M

macro-sensitivity

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BJDX VS. ICCM) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	BJDX	ICCM	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	36.30%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	-35.00%	0.00	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	—	—	—	TIE	/fcf-yield <GO>
Operating Margin	—	-60.00%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	-60.00%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	2.70%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	—	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	3/9	5/9	-2.00	ICCM	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	29.4	24.1	+5.30	BJDX	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$2.4M	$2.9M	-$519.7K	ICCM	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	BJDX REV	ICCM REV	BJDX GROSS %	ICCM GROSS %	BJDX FCF	ICCM FCF
FY 2025	$19.5M	$3.4M	—	36.3%	-$6.2M	-$14.6M
FY 2024	$20.1M	$3.3M	—	44.1%	-$8.1M	-$12.6M
FY 2023	$28.9M	$3.2M	—	—	-$8.3M	-$12.6M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

BJDX // BETA —

ICCM // BETA —